(NASDAQ: IFRX) Inflarx Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 44.08%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.53%.
Inflarx Nv's earnings in 2025 is -$46,631,580.On average, 9 Wall Street analysts forecast IFRX's earnings for 2025 to be -$46,989,409, with the lowest IFRX earnings forecast at -$48,466,297, and the highest IFRX earnings forecast at -$44,103,382. On average, 9 Wall Street analysts forecast IFRX's earnings for 2026 to be -$46,691,322, with the lowest IFRX earnings forecast at -$81,662,391, and the highest IFRX earnings forecast at -$32,010,519.
In 2027, IFRX is forecast to generate -$56,203,019 in earnings, with the lowest earnings forecast at -$110,211,031 and the highest earnings forecast at -$32,721,864.